Birdwatch Archive

Birdwatch Note

2023-12-02 05:08:11 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

COVID-19 vaccines are not dangerous untested products. COVID-19 vaccines have a reassuring safety profile and reduce COVID-19 hospitalization and death. Studies on adverse reactions show they're extremely rare https://www.nejm.org/doi/full/10.1056/nejmoa2110345 https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00345-0/fulltext https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00054-8/fulltext

Written by F735563C1D6CACAE98B239A5BF3B6B29334E5A32093D655B66C4A4A96408409D
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1730722108211356148

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1730816108716851595
  • noteId - 1730816108716851595
  • participantId -
  • noteAuthorParticipantId - F735563C1D6CACAE98B239A5BF3B6B29334E5A32093D655B66C4A4A96408409D Participant Details
  • createdAtMillis - 1701493691987
  • tweetId - 1730722108211356148
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 1
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • COVID-19 vaccines are not dangerous untested products. COVID-19 vaccines have a reassuring safety profile and reduce COVID-19 hospitalization and death. Studies on adverse reactions show they're extremely rare https://www.nejm.org/doi/full/10.1056/nejmoa2110345 https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00345-0/fulltext https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00054-8/fulltext

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-12-02 05:08:11 UTC
(1701493691987)		 1969-12-31 23:59:59 UTC
(-1)		 2023-12-03 04:27:56 UTC
(1701577676238)		 NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-12-02 15:58:04 -0600 Rating Details
2023-12-02 14:57:51 -0600 Rating Details
2023-12-02 14:57:11 -0600 Rating Details
2023-12-02 14:04:39 -0600 Rating Details
2023-12-02 12:31:39 -0600 Rating Details
2023-12-02 10:38:43 -0600 Rating Details
2023-12-02 09:27:44 -0600 Rating Details
2023-12-02 09:04:24 -0600 Rating Details
2023-12-02 08:07:22 -0600 Rating Details
2023-12-02 08:04:36 -0600 Rating Details
2023-12-02 07:42:56 -0600 Rating Details
2023-12-02 06:28:52 -0600 Rating Details
2023-12-02 06:18:24 -0600 Rating Details
2023-12-02 06:08:47 -0600 Rating Details
2023-12-02 05:15:11 -0600 Rating Details
2023-12-02 03:14:51 -0600 Rating Details
2023-12-02 03:04:20 -0600 Rating Details
2023-12-02 02:55:50 -0600 Rating Details
2023-12-02 02:09:57 -0600 Rating Details
2023-12-02 01:01:55 -0600 Rating Details
2023-12-02 01:00:27 -0600 Rating Details
2023-12-02 00:56:08 -0600 Rating Details
2023-12-02 00:53:46 -0600 Rating Details
2023-12-02 00:45:25 -0600 Rating Details
2023-12-02 00:41:43 -0600 Rating Details
2023-12-02 00:39:30 -0600 Rating Details
2023-12-02 00:32:08 -0600 Rating Details
2023-12-02 00:03:52 -0600 Rating Details
2023-12-01 23:55:22 -0600 Rating Details
2023-12-01 23:54:36 -0600 Rating Details
2023-12-01 23:46:11 -0600 Rating Details
2023-12-01 23:42:44 -0600 Rating Details
2023-12-03 11:35:37 -0600 Rating Details
2023-12-03 04:32:18 -0600 Rating Details
2023-12-02 21:13:49 -0600 Rating Details
2023-12-02 20:04:02 -0600 Rating Details
2023-12-02 18:41:53 -0600 Rating Details
2023-12-02 16:47:10 -0600 Rating Details
2023-12-02 16:30:20 -0600 Rating Details
2023-12-02 16:14:30 -0600 Rating Details
2023-12-02 15:00:51 -0600 Rating Details
2023-12-02 13:47:22 -0600 Rating Details
2023-12-02 12:17:37 -0600 Rating Details
2023-12-02 09:57:44 -0600 Rating Details
2023-12-02 07:10:05 -0600 Rating Details
2023-12-02 06:51:42 -0600 Rating Details
2023-12-02 06:34:34 -0600 Rating Details
2023-12-02 05:50:11 -0600 Rating Details
2023-12-02 05:28:33 -0600 Rating Details
2023-12-02 05:12:37 -0600 Rating Details
2023-12-02 05:01:05 -0600 Rating Details
2023-12-02 04:47:37 -0600 Rating Details
2023-12-02 04:25:58 -0600 Rating Details
2023-12-02 04:06:31 -0600 Rating Details
2023-12-02 04:00:53 -0600 Rating Details
2023-12-02 03:54:59 -0600 Rating Details
2023-12-02 03:32:30 -0600 Rating Details
2023-12-02 03:02:25 -0600 Rating Details
2023-12-02 02:51:07 -0600 Rating Details
2023-12-02 02:13:27 -0600 Rating Details
2023-12-02 02:08:08 -0600 Rating Details
2023-12-02 02:04:41 -0600 Rating Details
2023-12-02 01:55:30 -0600 Rating Details
2023-12-02 01:23:45 -0600 Rating Details
2023-12-02 01:23:39 -0600 Rating Details
2023-12-02 01:18:28 -0600 Rating Details
2023-12-01 23:44:05 -0600 Rating Details
2023-12-01 23:43:09 -0600 Rating Details
2023-12-01 23:41:07 -0600 Rating Details
2023-12-01 23:33:30 -0600 Rating Details
2023-12-06 14:13:43 -0600 Rating Details
2023-12-03 10:07:16 -0600 Rating Details
2023-12-02 15:12:30 -0600 Rating Details
2023-12-02 11:23:58 -0600 Rating Details
2023-12-02 08:47:29 -0600 Rating Details
2023-12-02 02:36:45 -0600 Rating Details
2023-12-02 02:27:36 -0600 Rating Details
2023-12-02 00:23:38 -0600 Rating Details
2023-12-02 00:02:19 -0600 Rating Details
2023-12-01 23:48:51 -0600 Rating Details
2023-12-01 23:38:32 -0600 Rating Details
2023-12-10 05:05:44 -0600 Rating Details
2024-02-19 00:51:44 -0600 Rating Details